Abstract
Inflammatory breast cancer (IBC) is the most aggressive and distinct form of primary breast cancer with a peculiar clinical presentation and dismal clinical outcome. This review addresses the pathologic aspects of this entity and discusses the molecular alterations involved in the highly malignant phenotype of IBC.
Original language | English (US) |
---|---|
Pages (from-to) | 33-40 |
Number of pages | 8 |
Journal | Seminars in oncology |
Volume | 35 |
Issue number | 1 |
DOIs | |
State | Published - Feb 2008 |
ASJC Scopus subject areas
- Hematology
- Oncology